The Medicines for Human Use (Clinical Trials) (Amendment) (EU Exit) Regulations 2019

Amendment of regulation 15 (ethics committee opinion)U.K.

This section has no associated Explanatory Memorandum

8.  In regulation 15(5)(e) M1, after “summary of product characteristics” insert “ , or equivalent document, ”.

Commencement Information

I1Reg. 8 in force at 31.12.2020 on IP completion day (in accordance with 2020 c. 1, Sch. 5 para. 1(1)), see reg. 1

Marginal Citations

M1Paragraph (5) was amended by S.I. 2006/1928.